Assessment of NeuroBOX and NeuroPAP in Infants.

NACompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

October 1, 2018

Primary Completion Date

October 31, 2021

Study Completion Date

October 31, 2021

Conditions
Pediatric Respiratory DiseasesBronchiolitisInfant Respiratory Distress Syndrome
Interventions
DEVICE

NeuroPAP ventilation (2h) and NeuroBox monitoring (23h)

Patients will be successively ventilated with conventional NIV (30 min with the conventional ventilator, 30 min with the NeuroBOX), and NeuroPAP (1 hour). An additional 20-hour period of recordings (with conventional NIV) will be conducted to characterize the neural breathing pattern, prevalence of apneas and tonic activation during conventional treatment. Finally, a second 1-hour period with NeuroPAP will be conducted

DEVICE

NeuroPAP ventilation (4h) and NeuroBox monitoring (25h)

Patients will be successively ventilated with conventional NIV (30 min with the conventional ventilator, 30 min with the NeuroBOX), and NeuroPAP (3 hours). An additional 20-hour period of recordings (with conventional NIV) will be conducted to characterize the neural breathing pattern, prevalence of apneas and tonic activation during conventional treatment. Finally, a second 1-hour period with NeuroPAP will be conducted

Trial Locations (1)

H3T 1C5

St. Justine's Hospital, Montreal

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Maquet Critical Care

UNKNOWN

lead

St. Justine's Hospital

OTHER

NCT03650478 - Assessment of NeuroBOX and NeuroPAP in Infants. | Biotech Hunter | Biotech Hunter